Penalva Juan C, Martínez Juan, Laveda Raquel, Esteban Angel, Muñoz Carlos, Sáez Jesús, Such José, Navarro Salvador, Feu Faust, Sánchez-Payá José, Pérez-Mateo M
Department of Internal Medicine, Hospital General Universitario Alicante, Hospital General Elche, Alicante, Spain.
J Clin Gastroenterol. 2004 Jul;38(6):512-7. doi: 10.1097/01.mcg.0000129060.46654.e0.
There is scarce information regarding intestinal permeability (IP) in patients with acute pancreatitis (AP) and its relationship with systemic inflammatory response and bacterial translocation (BT).
To study IP in patients with mild and severe forms of AP as compared with controls and the presumed correlations between IP, the inflammatory response, and endotoxin.
Sixty-eight patients with AP and 13 healthy controls were included. IP was assessed by means of the lactulose/mannitol (L/M) test, at admission (LMR1), and at the 15th day (LMR2). The presence of endotoxin was assessed by means of endotoxin-core antibodies type IgM (EndoCab IgM), at admission and 15 days later in patients with severe AP. Plasma levels of interleukins 6, 8, 10, and tumor necrosis factor alpha were tested within the first 72 hours from the onset of pain.
Both LMR1 and LMR2 were significantly higher in patients than in controls, and in patients with severe versus mild forms of AP. Plasma levels of Endocab IgM increased significantly in patients with severe AP. Basal plasma levels of pro- and anti-inflammatory cytokines were significantly higher in patients with severe AP. A significant correlation was found between LMR2 and Endocab IgM levels in patients with severe AP (r = 0.73, P = 0.02).
Patients with AP show an increased IP when compared with controls, being more relevant and persistent in severe cases. This seems related to an increase of endotoxemia late in the course of the disease, but not with an exacerbation of the systemic immune response.
关于急性胰腺炎(AP)患者的肠道通透性(IP)及其与全身炎症反应和细菌移位(BT)的关系,目前信息匮乏。
研究轻度和重度AP患者与对照组相比的IP情况,以及IP、炎症反应和内毒素之间的假定相关性。
纳入68例AP患者和13例健康对照。通过乳果糖/甘露醇(L/M)试验在入院时(LMR1)和第15天(LMR2)评估IP。通过IgM型内毒素核心抗体(EndoCab IgM)在入院时和重度AP患者15天后评估内毒素的存在情况。在疼痛发作后的前72小时内检测白细胞介素6、8、10和肿瘤坏死因子α 的血浆水平.
患者的LMR1和LMR2均显著高于对照组以及重度AP患者与轻度AP患者相比。重度AP患者的Endocab IgM血浆水平显著升高。重度AP患者促炎和抗炎细胞因子的基础血浆水平显著更高。在重度AP患者中发现LMR2与Endocab IgM水平之间存在显著相关性(r = 0.73,P = 0.02)。
与对照组相比,AP患者的IP增加,在严重病例中更明显且持续时间更长。这似乎与疾病后期内毒素血症的增加有关,但与全身免疫反应的加剧无关。